The Prader-Willi-like phenotype in fragile X patients: a designation facilitating clinical (and molecular) differential diagnosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Height and BMI in fragile X syndrome: A longitudinal assessment.Obesity (Silver Spring, Md.) · 2022
   Article
2. The neurobiology of the Prader-Willi phenotype of fragile X syndrome.Intractable & rare diseases research · 2016
   Review
3. The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.Human molecular genetics · 2015
   Article
4. Type II diabetes and impaired glucose tolerance due to severe hyperinsulinism in patients with 1p36 deletion syndrome and a Prader-Willi-like phenotype.BMC medical genetics · 2014
   Article
5. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.Genes, brain, and behavior · 2012
   Article
6. FMR1 premutation and full mutation molecular mechanisms related to autism.Journal of neurodevelopmental disorders · 2011
   Article
7. Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.American journal of medical genetics. Part A · 2008
   Article
8. Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.BMC genomics · 2008
   Article
9. Autism: the point of view from fragile X studies.Journal of autism and developmental disorders · 1998
   Review
10. The fragile X syndrome.Journal of medical genetics · 1998
    Review

Corrections and comments

• Comment on
  Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.1994

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as